We hypothesized that the immune cells in TME might be involved in the tumor-promotive function of RUFY4 based on the findings that RUFY4 functioned little on migration and invasion of ccRCC. This evidence concerns the gene RUFY4 and nonpapillary renal cell carcinoma.